PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026Circulation Heart Failure0 citations

Simtuzumab's Role in Cardiac Function Preservation in Lmna Mutation-Driven Disease

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in LMNA Mutation-Induced Dilated Cardiomyopathy

View Full Paper

Why the study?

Does simtuzumab preserve cardiac function in LMNA mutation-induced dilated cardiomyopathy?

Population

LMNA mutation-induced dilated cardiomyopathy

Design

Preclinical

Key result

Loxl2 inhibition with simtuzumab attenuates extracellular matrix remodeling and preserves cardiac function in LMNA-associated dilated cardiomyopathy.

Authors

MKMarie KervellaCBCharlotta Sophie BehrensCPCécile Peccate

Discussion

Loading...

Member takes

Overview

Should not yet change practice in LMNA-associated DCM; supports Loxl2 inhibition as a potential therapeutic strategy.

Key Points

  • This research investigates the role of loxl2 in cardiac function and its potential as a therapeutic target.
  • Assessed effects of simtuzumab on loxl2-mediated extracellular matrix remodeling
  • Evaluated cardiac function in models with LMNA mutations
  • Simtuzumab treatment reduced loxl2 activity
  • Preserved cardiac function was observed in treated subjects

Structured PICO

Does simtuzumab preserve cardiac function in LMNA mutation-induced dilated cardiomyopathy?

P
Population
LMNA mutation-induced dilated cardiomyopathy
I
Intervention
Simtuzumab (Loxl2 inhibition)
O
Outcome
Extracellular matrix remodeling and cardiac functionsurrogate

Loxl2 inhibition with simtuzumab represents a potential therapeutic strategy to preserve cardiac function in LMNA-associated dilated cardiomyopathy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kervella et al. (2026) studied this question. Loxl2 inhibition with simtuzumab attenuates extracellular matrix remodeling and preserves cardiac function in LMNA-associated dilated cardiomyopathy.

synapsesocial.com/papers/69bb928c496e729e6297ff83https://doi.org/10.1161/circheartfailure.125.013806
Ask AI
Helpful
Bookmark
Share
View Full Paper